INDIANAPOLIS – Roche Diagnostics has launched the CoaguChek Vantus system, a self-testing device for coagulation monitoring with Bluetooth technology. Using the system, patients can use their tablet or smartphone with a compatible app to send their results automatically to their provider via wireless connectivity. “As health care systems face continued pressure to deliver improved access to care at a lower cost, increased connectivity between health care providers and patients becomes even more important,” said Dr. Alan Wright, chief medical officer at Roche Diagnostics, in a statement. “This innovative technology sets the standard in coagulation monitoring by providing high quality, convenient testing, while optimizing the patient result reporting workflow. The CoaguChek Vantus system also features medication and testing reminders, the ability to flag results in relation to the target range and the option to insert comments to the result. The hand-held device enables patients to conveniently monitor international normalized ratio (INR) results with an intuitive user-interface, while enabling flexible remote connectivity to their health care providers through Bluetooth technology. Trend report functionality also provides both patients and their health care providers with an overview on the stability of their anticoagulation levels.
You are here: / / Roche launches CoaguCheck system